News | January 04, 2023
Themis Medicare launches Lenzetto for treatment of menopausal symptoms
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
BDRs journey for the treatment of Prostate Cancer started with Abiratarone Acetate, then Leuprolide Acetate followed by Enzalutamide and, then Degarelix and Triptorelin.
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
To create leading company developing medicines targeting metalloenzymes
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
The company is one of the most profitable companies manufacturing speciality chemicals in India
Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor, offering patients a novel mechanism
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
Subscribe To Our Newsletter & Stay Updated
